Targeting molecular networks for drug research
暂无分享,去创建一个
Matthias E. Futschik | Rui S. R. Machado | José P. Pinto | Joana M. Xavier | J. P. Pinto | M. Futschik | J. Xavier | J. Pinto
[1] Diogo M. Camacho,et al. Wisdom of crowds for robust gene network inference , 2012, Nature Methods.
[2] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[3] Erich E. Wanker,et al. UniHI: an entry gate to the human protein interactome , 2006, Nucleic Acids Res..
[4] Hongkang Mei,et al. Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network , 2013, PLoS Comput. Biol..
[5] D. di Bernardo,et al. Reverse engineering a mouse embryonic stem cell-specific transcriptional network reveals a new modulator of neuronal differentiation , 2012, Nucleic acids research.
[6] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[7] Khusru Asadullah,et al. What makes a good drug target? , 2011, Drug discovery today.
[8] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[9] E. Tobinick. The value of drug repositioning in the current pharmaceutical market. , 2009, Drug news & perspectives.
[10] Erich E. Wanker,et al. Comparison of Human Protein-Protein Interaction Maps , 2007, German Conference on Bioinformatics.
[11] S. Mathur,et al. Drug repositioning using disease associated biological processes and network analysis of drug targets. , 2011, AMIA ... Annual Symposium proceedings. AMIA Symposium.
[12] B. Al-Lazikani,et al. Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.
[13] A. Wagner. Distributed robustness versus redundancy as causes of mutational robustness. , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.
[14] Christopher L. McClendon,et al. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.
[15] N. Katsanis,et al. Human genetics and disease: Beyond Mendel: an evolving view of human genetic disease transmission , 2002, Nature Reviews Genetics.
[16] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[17] Sunghoon Kim,et al. Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug , 2012, BMC Systems Biology.
[18] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[19] Illés J. Farkas,et al. Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discovery , 2010, Bioinform..
[20] Yoshihiro Yamanishi,et al. Relating drug–protein interaction network with drug side effects , 2012, Bioinform..
[21] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[22] F. Prinz,et al. Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.
[23] Ruth Nussinov,et al. Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.
[24] H. Deng,et al. Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds , 2013, Science.
[25] Matthias E. Futschik,et al. UniHI 7: an enhanced database for retrieval and interactive analysis of human molecular interaction networks , 2013, Nucleic Acids Res..
[26] Y. Moreau,et al. Finding the targets of a drug by integration of gene expression data with a protein interaction network. , 2013, Molecular bioSystems.
[27] Damian Szklarczyk,et al. STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..
[28] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[29] Teri A Manolio,et al. Genomewide association studies and assessment of the risk of disease. , 2010, The New England journal of medicine.
[30] Julio Saez-Rodriguez,et al. DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data , 2012, Bioinform..
[31] Wenjun Guo,et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds , 2008, Nature Biotechnology.
[32] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[33] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[34] Uma Lakshmipathy,et al. Pluripotent Stem Cells , 2013, Methods in Molecular Biology.
[35] Chuang Liu,et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..
[36] R. Albert. Scale-free networks in cell biology , 2005, Journal of Cell Science.
[37] M. Oti,et al. The modular nature of genetic diseases , 2006, Clinical genetics.
[38] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[39] J. Hopfield,et al. From molecular to modular cell biology , 1999, Nature.
[40] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[41] José Pedro Basto Gouveia Pereira Pinto. Computational tools for large-scale biological network analysis , 2012 .
[42] W-C Hwang,et al. Identification of Information Flow‐Modulating Drug Targets: A Novel Bridging Paradigm for Drug Discovery , 2008, Clinical pharmacology and therapeutics.
[43] A. Bonato,et al. Dominating Biological Networks , 2011, PloS one.
[44] Lin He,et al. DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..
[45] Philip E. Bourne,et al. PROMISCUOUS: a database for network-based drug-repositioning , 2010, Nucleic Acids Res..
[46] Jennifer Nichols,et al. Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition , 2008, PLoS biology.